InflaRx (IFRX) Total Debt (2020 - 2025)
InflaRx's (IFRX) quarterly Total Debt came in at $5.2 million in Q2 2025, up 3465.43% quarter-over-quarter from $144451.4 in Q3 2022.
Analysis
InflaRx (IFRX) Total Debt (2020 - 2025) Analysis & Trends
InflaRx has disclosed Total Debt across 4 years of filings, most recently posting $5.2 million for Q2 2025.
- In Q2 2025, Total Debt changed N/A year-over-year to $5.2 million; the TTM figure through Jun 2025 stood at $5.2 million (changed N/A YoY), while the FY2021 annual figure was $158103.6, up 12.64% from the prior year.
- Total Debt came in at $5.2 million for Q2 2025 at InflaRx, up from $144451.4 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $5.2 million in Q2 2025 to a low of $139078.0 in Q2 2022.
- Average Total Debt over 3 years is $903141.8, with a median of $150512.3 recorded in 2021.
- Year-over-year, Total Debt increased 12.64% in 2021 and tumbled 65.88% in 2022.
- Over 3 years, Total Debt stood at $158103.6 in 2021, then declined by 8.63% to $144451.4 in 2022, then surged by 3465.43% to $5.2 million in 2025.
- Per Business Quant data, the three most recent Total Debt figures were $5.2 million in Q2 2025, $144451.4 in Q3 2022, and $139078.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 62.75 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 28.66 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 8.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 5.15 Mn |
| Sep 30, 2022 | 144,451.43 |
| Jun 30, 2022 | 139,078.03 |
| Mar 31, 2022 | 147,432.53 |
| Dec 31, 2021 | 158,103.65 |
| Jun 30, 2021 | 150,512.25 |
| Mar 31, 2021 | 432,094.28 |
| Dec 31, 2020 | 140,364.71 |